This is an open access book.
This book provides a distinctive perspective on the daily utilization and consumption of medicines and drugs. It seamlessly integrates the research traditions of the medical and pharmaceutical realms with the approach of fostering the relationship between users and products, a characteristic of design and user studies. By applying a diverse range of expertise, the authors endeavor to reestablish the interconnectedness of issues that place the drug and the indispensable information for its use directly into the hands of the patient. The primary objective is to formulate an initial set of recommendations and compile a repertoire of best practices. Consequently, this book becomes an indispensable resource for students, professionals, and academics engaged in design culture, as well as those operating within the healthcare domain, such as the pharmaceutical industry, medical practitioners, and pharmacists. It is equally valuable for individuals working in institutions responsible for regulating medicines and overseeing their presence in the market. As a comprehensive guide, this book serves as an essential read, offering insights that bridge the gap between various sectors involved in the intricate landscape of medicine and drug consumption.
1 Towards in-home medication: Medicinal products as daily objects.- Part 1 Objects of science: the pharmaceutical industry as a place of preciseness.- 2 Medicine packaging legislation and its evolution according to technological innovation for better healthcare support.- Addendum 1 – Regulatory references. - 3 Primary medicine packaging and quality control.- 4 Pharmaceutical forms and primary packaging: a glossary.- 5 Secondary packaging of medicines: design processes for the pharmaceutical industry.- 6 Secondary packaging and leaflets: a glossary.- Part 2 Prescribing and dispensing: accompanying the patient to the correct use of medicines.- 7 Moving the care process in the in-home context: the therapeutic prescription.- 8 Dispensing medicines: A necessary link between doctor and patient.- 9 The future digital pharmacological prescription between therapy adherence and integrated healthcare personal plans.- 10 Navigating the complexities of the OTC medicine ecosystem.- 11 Dealing with medicines through online platforms and communities.- Addendum 2 – Medication errors data.- Part 3 The daily life as a place of inaccuracy - the domesticity of therapy.- 12 Medicines as designed objects.- 13 The in-home place of medications: perspectives of domestication.- 14 In-home: Medicinals treatment as a learning process.- 15 Use phenomenologies. Observing the user while taking pharmaceutical therapies.- 16 Use phenomenologies. Oral solid forms in blister packs.- 17 Use phenomenologies. What does the user do with the secondary medicine packaging and package leaflet?.- Part 4 - The pharmaceutical product system: premises for the definition of a repertory of good practices.- 18 How political and cultural challenges are impacting pharma industries.- 19 Medicinal products: when innovation meets the patient.- 20 Pharmaceutical packaging according to the “Packaging Ethics Charter”.- 21 Sensory qualities of the medicines: from problems to proposals.- 22 Compendium: step toward design-oriented practices in the pharma industry in a multidisciplinary perspective.- Addendum 3 The name of medicines. LASA medicines.- Addendum 4 – Methods of user involvement.- Addendum 5 – Error Reporting Procedures.
Height:
Width:
Spine:
Weight:0.00